- Home
- GRWG vs ONCY Comparison
GRWG vs ONCY Comparison
Compare GRWG & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRWG | ONCY |
|---|---|---|
| Founded | 2008 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.2M | 94.0M |
| IPO Year | 2015 | 2002 |
Fundamental Metrics
Financial Performance| Metric | GRWG | ONCY |
|---|---|---|
| Price | $1.08 | $0.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $2.50 | ★ $7.33 |
| AVG Volume (30 Days) | 280.2K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,365,479.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 142.51 | N/A |
| 52 Week Low | $0.83 | $0.33 |
| 52 Week High | $2.40 | $1.51 |
Technical Indicators
Market Signals| Indicator | GRWG | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 46.42 |
| Support Level | $1.06 | $0.94 |
| Resistance Level | $1.09 | $1.10 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 5.00 | 12.87 |
Price Performance
Historical ComparisonAbout GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.